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Abstract. We have previously reported that Ser13 and 
Ser34 on glial fibrillary acidic protein (GFAP) in the 
cleavage furrow of glioma cells are phosphorylated dur- 
ing late mitotic phase (Matsuoka, Y., K. Nishizawa, T. 
Yano, M. Shibata, S. Ando, T. Takahashi, and M. Ina- 
gaki. 1992. EMBO (Eur. Mol. Biol. Organ.) Z  11:2895- 
2902). This observation implies a possibility that there 
is a protein kinase specifically activated at metaphase- 
anaphase transition. To further analyze the cell cycle- 
dependent GFAP phosphorylation, we prepared mono- 
clonal antibodies KT13 and KT34 which recognize the 
phosphorylation of GFAP at Serl3 and Ser34, respec- 
tively. Immunocytochemical  studies with KT13 and 
KT34 revealed that the GFAP phosphorylation in the 
cleavage furrow during late mitotic phase occurred not 
only in glioma cells but also in human SW-13 and 
mouse Ltk- cells in which GFAP was ectopically ex- 
pressed, thus the phosphorylation can be monitored in 
a wide range of cell types. Furthermore, we detected ki- 
nase activity which phosphorylates GFAP at Serl3 and 
Ser34 in the lysates of late mitotic cells but not in those 
of interphase cells or early mitotic cells. These results 
suggest that there exists a protein kinase which is spe- 
cifically activated at the transition of metaphase to 
anaphase not only in GFAP-expressing cells but also in 
cells without GFAP. 
C 
ELL-DIVISION cycle  is  the  fundamental means by 
which cells duplicate, and comprises a complicated 
series of cytoplasmic and nuclear events which are 
elaborately coordinated under the control. It has become 
increasingly  evident that the cell cycle control system is 
based on protein phosphorylation (for reviews see Nurse, 
1990; Norbury and Nurse,  1992). Accumulating evidence 
has revealed that mitotic cyclins, G1  cyclins, and cyclin- 
dependent protein  kinases  (cdks) x play critical  roles  in 
controlling the cell  cycle  at G2-M  and G1-S transitions 
(for reviews see Hunt, 1989, 1991; Reed, 1992; Pines, 1993; 
Sherr,  1993; Nigg, 1993). On the other hand, the mecha- 
nisms that govern the cell cycle from metaphase-anaphase 
transition to the end of mitosis are largely unknown. Some 
proteins were reported to be phosphorylated during late 
mitotic phase, indicating that protein kinases may contrib- 
ute to the execution and control of the events (Johnston 
and  Sloboda,  1992; Yamakita  et  al.,  1994; Toyn  and 
Johnston, 1994). However, limited information is available 
on kinases activated during late mitotic phase (Fenton and 
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Glover, 1993; Kitada et al., 1993; Samejima and Yanagida, 
1994). 
Phosphorylation state-specific  antibodies which recog- 
nize  a  phosphorylated serine/threonine  residue  and  its 
flanking sequence provide a useful tool to analyze phos- 
phorylation of proteins in vivo  (Nishizawa  et  al.,  1991; 
Czernik et al., 1991; Matsuoka et al., 1992; Inagaki et al., 
1994a,b). Glial fibrillary acidic protein (GFAP) is an inter- 
mediate filament protein expressed  in the cytosol of glial 
cells (Lazarides,  1980). Recently, we reported two distinct 
types of GFAP phosphorylation during mitosis  of U251 
glioma cells, using antibodies that recognize  GFAP phos- 
phorylation (Matsuoka et al.,  1992). One type is GFAP 
phosphorylation at Ser8 residue which appeared at G2-M 
transition,  remained  until  metaphase,  and  declined  in 
anaphase.  The  phosphorylation  was  observed  diffusely 
throughout the cytoplasm.  On the basis of evidence that 
cdc2 kinase activity is maximal at G2-M transition (Nurse, 
1990; Pines and Hunter, 1990) and that Ser8 is phosphory- 
lated in vitro by cdc2 kinase,  we concluded that cdc2 ki- 
nase is responsible  for the phosphorylation (Tsujimura et 
al., 1994a). Using a monoclonal antibody specifically rec- 
ognizing vimentin, another intermediate filament protein, 
phosphorylated at Ser55, we demonstrated that cdc2 ki- 
nase is responsible  for phosphorylation of vimentin in the 
entire  cytoplasm at  G2-M  transition  (Tsujimura  et  al., 
1994b). The other type is GFAP phosphorylation at Thr7, 
Ser13, and Set34, which appeared at metaphase-anaphase 
transition, was maintained until telophase and decreased 
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tween the daughter nuclei and in the cleavage furrow. The 
specific localization  of GFAP  phosphorylation  suggests 
that it may play an important role in efficient separation of 
glial filaments to daughter cells. This observation also im- 
plies a possible existence of a protein kinase which is spe- 
cifically activated at metaphase-anaphase transition. How- 
ever, with polyclonal antibodies it was difficult to obtain 
clear data  for the  demonstration  of kinase  activity, be- 
cause there was  a  minor population that recognized un- 
phosphorylated GFAP and additional unknown proteins 
(Nishizawa et al., 1991; Matsuoka et al., 1992). 
To overcome the  difficulty, we developed monoclonal 
antibodies, KT13 and KT34 which recognize the phosphor- 
ylation state of GFAP at Ser13 and Ser34, respectively. 
Immunocytochemical studies  with  KT13  and  KT34  re- 
vealed that the cell cycle-dependent phosphorylation of 
GFAP at Serl3 and Ser34 is observed in a wide range of 
cell types during late mitotic phase. We also obtained evi- 
dence for a kinase activity which phosphorylates GFAP at 
Serl3 and Ser34 in lysates of late mitotic cells but not in 
those of interphase cells or early mitotic cells. 
Materials and Methods 
Purification of Proteins 
The catalytic subunit of cAMP-dependent protein kinase (PKA) was pre- 
pared from bovine heart by the method of Beavo et al. (1974).  A human 
GFAP cDNA (pBabe-neo-GFAP) was kindly provided by Dr. James T. 
Rutka (Rutka et al., 1994). For bacterial expression, a 5' NdeI site was en- 
gineered  at  the  beginning of the  coding  segment by  oligonucleotide- 
directed mutagenesis using a 5' primer (5'-ACAAGCqTCATATGGAG- 
AGGAGACG-Y), then the mutated coding segment was subcloned into 
the  NdeI-BamHI  sites  of  prokaryotic  expression  vector,  pET-3a 
(Novagene,  Madison,  WI).  Escherichia  coli  strain  BL21(DE3)pLysS 
(Ogawara et al., 1995) was transformed with the plasmid and the induc- 
tion of GFAP expression was achieved by 6 h incubation of the bacteria 
with 0.5  mM isopropyl-[3-o-thiogalactopyranoside in  LB  medium. The 
transformants were harvested by centrifugation at 8,000 g for 15 rain and 
stored at  -80°C. Recombinant GFAP was purified as described previ- 
ously (Inagaki et al., 1990). Protein concentration was determined by the 
method of Bradford (1976), using bovine serum albumin as a standard. 
Phosphorylation of GFAP 
After  dialysis  against  2  mM  ethylene  glyeol-bis([3-aminoethyl  ether) 
N,N,N',N',-tetraacetie acid (EGTA), 50 mM 2-mercaptoethanol (2-ME), 
1 mM PMSF, and 5 mM Tris-HC1 (pH 8.8) for 24 h at 4°C, purified GFAP 
(0.15  mg/ml) was phosphorylated by incubation with 5 ixg/ml PKA, 0.1 
mM ATP, 3 mM MgCI  2, 25 mM Tris-HCl (pH 7.5) for 1 h at 25°C. 
Cell Culture and Transfection 
Human glioma U251 cells, mouse fibroblastie Ltk- cells, and human adre- 
nal cortex carcinoma-derived SW-13  cells were maintained in DMEM 
supplemented with 10% FCS and L-glutamine. To express human GFAP 
in Ltk- and SW-13 cells, the 1,314-bp EcoRI-BamHI fragment of pBabe- 
neo-GFAP was introduced into the pRc/CMV vector (Invitrogen, San Di- 
ego, CA), and then the cells were transfected with the plasmid (4 ixg/ml) 
using 10 p~g/ml Lipofectin (GIBCO BRL, Gaithersburg, MD). The cells 
expressing human GFAP were cloned and maintained in the presence of 
500 p.g/ml G418 sulfate (GIBCO BRL). 
Peptide Synthesis and Production of Hybridomas 
GFAP peptides, PG13 (Cys-Ser-Ala-Ala-Arg-Arg-phosphoSer13-Tyr-Val  - 
Ser-Ser-Leu), G13 (Cys-Ser-Ala-Ala-Arg-Arg-Ser-Tyr-Val-Ser-Ser-Leu), 
PG34  (Cys-Pro-Gly-Pro-Arg-Leu-phosphoSer34-Leu-Ala-Arg-Met-Pro), 
G34 (Cys-Pro-Gly-Pro-Arg-Leu-Ser-Leu-Ala-Arg-Met-Pro),  PG389 (Cys- 
Gln-Ile-Arg-Glu-Thr-phosphoSer3S9-Leu-Asp-Thr-Lys-Ser),  and  G389 
(Cys-Gln-Ile-Arg-Glu-Thr-Ser-Leu-Asp-Thr-Lys-Ser) were  synthesized 
and purified as described previously (Tsujimura  et  al.,  1994b).  Mono- 
clonal antibodies against phosphopeptide PG13 (KT13) and phosphopep- 
tide PG34 (KT34) were produced, following the method described previ- 
ously  (Yano  et  al.,  1991; Tsujimura  et  al.,  1994b).  The  monoclonal 
antibody MO389  which reacted with both phosphopeptide PG389  and 
nonphosphopepfide G389 was also developed using the same procedures 
with phosphopeptide PG389 as the antigen. 
Immunoblots 
All the procedures have been described in detail elsewhere (Yano et al., 
1991; Nishizawa et al., 1991). 
Immunofluorescence Microscopy 
Cells growing on glass coverslips were fixed in 3.7% formaldehyde in ice- 
cold PBS for 15 min and permeabilized with 0.1% Triton X-100 in PBS for 
10 min at room temperature. The cells were then incubated for 1 h  at 
room temperature with the monoclonal antibodies, KT13 or MO389 (dilu- 
tion 1:20). For immunostaining with monoclonal antibody KT34, the fixed 
cells were treated with methanol at  -20°C for 10 min instead of Triton 
X-100. After being washed three times with PBS, they were incubated for 
1 h with FITC-conjugated goat anti-mouse antibodies (dilution 1:1,000) 
(BIOSOURCE, Camarillo, CA), and stained with 25 ~g/ml propidium io- 
dide (PI) (Sigma) for 15 rain at room temperature. 
Preparation of lnterphase, Metaphase, and Late 
Mitotic Cells 
Intcrphase and metaphase U251  cells were prepared as described previ- 
ously (Nishizawa et al., 1991; Tsujimura et al., 1994b). In brief, U251 cells 
were plated onto 10-cm dishes, and then were arrested in metaphase by 
the addition of 10 ng/ml colcemid (GIBCO BRL) for 12 h. Metaphase 
cells were collected by mechanical shake off and the adherent ceils were 
used as interphase cells. Late mitotic U251  cells were prepared as de- 
scribed by Hosoya et al.  (1993)  but with slight modification. Cells were 
first cultured for 12 h in normal growth medium containing 50 ng/ml no- 
codazole (GIBCO BRL). Mitotic cells were detached by gentle pipetting, 
collected, rinsed twice in DMEM, suspended in nocodazole free growth 
medium and plated onto the culture dish. After removal of nocodazole, 
the population of late mitotic cells reached a peak in 30 min. 
Detection of Protein Kinase Activities That 
Phosphorylate Serl3 and Ser34 of GFAP 
5 X 106 U251  cells were suspended in an extraction buffer containing 0.5 
mM dithiothreitol, 2  mM EGTA, 20  mM 13-glycerophosphate, 5  ixg/ml 
leupeptin, 10 mM 2-ME, 100 mM NaC1, 1 mM PMSF, and 20 mM Tris- 
HCI (pH 8.0), sonicated and centrifuged at 100,000 g for 30 rain. For the 
detection of the kinase activity to phosphorylate Serl3 or Ser34, the solu- 
ble fraction  (0.6  mg protein/ml) was  incubated for 1  h  using purified 
GFAP (0.15 mg/ml) as an exogenous substrate in i mM ATP, 0.1 p,M caly- 
culin A, 3 mM MgC12, and 25 mM Tris-HCl (pH 7.5) at 25°C. Reactions 
were stopped by adding an equal volume of sodium dodecyl sulfate (SDS) 
sample buffer which contained 0.2 mg/ml Bromophenol blue, 10% glyc- 
erol, 100 mM 2-ME, 2% SDS, and 62.5 mM Tris-HCl (pH 6.8), and boiled 
for 1 min. Phosphorylated GFAP was analyzed by Western blotting as de- 
scribed above except that  detection was  achieved using the  enhanced 
chemiluminescence method (Amersham Corp., Arlington Heights, IL). 
Results 
Production and Characterization of Monoclonal 
Antibodies KT13 and KT34 
To analyze the phosphorylation of GFAP during late mi- 
totic  phase,  we  developed  two  monoclonal  antibodies 
KT13  and  KT34,  raised  against  the  synthetic  peptides 
PG13  (Cys-Ser-Ala-Ala-Arg-Arg-phosphoSerla-Tyr-Val  - 
Ser-Ser-Leu) and PG34 (Cys-Pro-Gly-Pro-Arg-Leu-phos- 
phoSer34-Leu-Ala-Arg-Met-Pro), respectively. The reac- 
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and KT34 analyzed by Western blotting. (A) Reac- 
tivity of KT13 and KT34 to unphosphorylated and 
phosphorylated  GFAP.  Unphosphorylated  GFAP 
(a, c, and e) and GFAP phosphorylated at 1.8 mol 
phosphate/mol protein by PKA (b, d, and f), were 
resolved by SDS-PAGE (75 ng in each lane)  and 
transferred  onto a  polyvinylidene difluoride  filter 
(PVDF) membrane.  Both Serl3 and Ser34  are re- 
ported to be phosphorylated by PKA in vitro (Ina- 
gaki et al., 1990). The blots were then stained with 1 
p,g/ml MO389 (a and b), 1 i~g/ml KT13 (c and d), or 
1 txg/ml KT34 (e and f). (B) Specificity of KT13 de- 
termined by inhibition assay. GFAP phosphorylated 
by PKA (75 ng in each lane) was stained with 1 ixg/ 
ml KT13 preincubated with 133 I~g/ml of nonphos- 
phopeptide  G13 (b), phosphopeptide PG13 (c),  or 
phosphopeptide  PG34  (d).  As  a  control,  lane  a 
shows the reactivity of KT13 after preincubation with PBS. (C) Specificity of KT34 determined by the same procedures as described in 
B. 1 ixg/ml KT34 was preincubated with 133 p~g/ml of nonphosphopeptide G34 (b), phosphopeptide PG13 (c), or phosphopeptide PG34 
(d). As a control, 1 p~g/ml KT34 was preincubated with PBS. Arrowheads indicate the position of GFAP. 
tivity  of  KT13  and  KT34  to  GFAP  phosphorylated  at 
Serl3  and  Ser34  and  to  unphosphorylated  GFAP  was 
checked  by Western  blotting.  Fig.  1 A  shows  that  KT13 
and KT34 reacted with the phosphorylated GFAP but not 
with  unphosphorylated  GFAP.  On the  other  hand,  anti- 
GFAP antibody MO389 recognized both the phosphory- 
lated  and unphosphorylated  GFAPs (Fig.  1 A). Next,  to 
examine  the epitope  specificity of these  antibodies,  com- 
petition  experiments  were  carried  out using various syn- 
thetic  peptides.  Preincubation  of KT13  with  phospho- 
peptide  PG13  but  not  with  nonphosphopeptide  G13  or 
phosphopeptide  PG34 prevented  the  binding of KT13 to 
the phosphorylated  GFAP (Fig.  1 B).  Likewise,  preincu- 
bation  of KT34 with phosphopeptide  PG34 but not with 
nonphosphopeptide  G34  or  phosphopeptide  PG13  pre- 
vented  the  reaction  of  KT34  with  the  phosphorylated 
GFAP (Fig. 1 C). Thus, KT13 and KT34 specifically recog- 
nize the phosphorylation of GFAP at Serl3 and at Ser34, 
respectively. 
GFAP Phosphorylation during Late Mitotic Phase Was 
Monitored in Various Types of Cells 
Fig.  2,  a  and  b  show  U251  glioma  cells  immunostained 
with  MO389  and  KT13,  respectively.  MO389  detected 
GFAP distributed throughout the cytoplasm. On the other 
hand,  the  KT13  immunoreactivity  was  observed  specifi- 
cally between the daughter nuclei and in the cleavage fur- 
row of U251 cells. The immunoreactivity appeared at the 
onset of anaphase was maintained until telophase, and de- 
Figure  2.  Fluorescence  photomi- 
crographs  showing  MO389  and 
KT13  immunoreactivity  in  U251 
glioma cells  and GFAP-introduced 
nonglial cells. Human glioma U251 
cells (a and b), human adrenal cor- 
tex  carcinoma  SW-13  cells  trans- 
fected  with  the  GFAP  expression 
vector (c and d), and mouse fibro- 
blastic  Ltk-  cells  transfected  with 
GFAP expression vector (e and f) 
were  fixed,  reacted  with  mono- 
clonal antibody MO389 (a, c, and e) 
or KT13 (b, d, and)"), and visualized 
by  FITC-conjugated  second  anti- 
body  (green).  The  chromosomes 
were stained with PI (red). The cells 
in a and b are in anaphase and those 
in c-f are in telophase.  Bar repre- 
sents 10 Ixm. 
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showing the specificity of KT13 and KT34 im- 
munoreactivities  in U251 glioma cells. Anti- 
bodies KT13 (a, b, and c) and KT34 (d, e, and 
f) (1 t~g/ml) were preincubated with 50 ixg/ml 
of phosphopeptides PG13 (b and e) or PG34 
(c and f), and then used for immunostaining. 
As a control,  a and d show the reactivity  of 
these  antibodies  after  preincubation  with 
PBS.  Arrows indicate  late  mitotic  cells. Bar 
represents 20 txm. 
creased  at the  exit of mitosis. These results confirm our 
previous observations with polyclonal anti-phosphoGFAP 
antibodies (Nishizawa et al., 1991; Matsuoka et al., 1992). 
Next, we asked whether Ser13 of GFAP would be simi- 
larly  phosphorylated  when  GFAP  was  introduced  into 
nonglial  cell  lines.  Human  adrenal  cortex  carcinoma- 
derived  SW-13  cells  and  mouse  fibroblastic  Ltk-  cells 
were stably transfected with the GFAP expression vector 
and immunostained with MO389 (Fig. 2, c and e). The ex- 
pressed GFAP was distributed diffusely in the cytoplasm 
of SW-13  and  Ltk-  cells  as  in  the  case  of endogenous 
GFAP  in  U251  cells.  Immunofluorescence  studies  with 
KT13 revealed that Serl3 of the ectopic GFAP in SW-13 
and  Ltk-  cells  was  also  phosphorylated  in  the  cleavage 
furrow during late mitotic phase (Fig. 2, d and f). These re- 
suits clearly demonstrate that the  Serl3  phosphorylation 
of GFAP can be monitored not only in glial cells but also 
in nonglial cells, regardless of species. Similar results were 
obtained with KT34 (Fig. 3 d, and data not shown). 
To examine the  specificity of KT13  and  KT34 immu- 
noreactivities, competition experiments were carried out. 
Preincubation of KT13 with phosphopeptide PG13 but not 
with phosphopeptide PG34 or PBS prevented the immuno- 
staining of KT13 (Fig. 3, a, b, and c). Similarly, the immuno- 
staining  with  KT34  was  abolished  by  preincubation  of 
KT34 with phosphopeptide PG34 but not with phospho- 
peptide PG13 or PBS (Fig. 3, d, e, and j). These observa- 
tions confirm the specificity of KT13 and KT34 immuno- 
stainings. 
Detection of Cleavage Furrow Kinase Activity in Late 
Mitotic Cell Lysates 
A  possible  mechanism  to  explain  our  findings  is  that 
GFAP is phosphorylated by a  kinase which is specifically 
activated in the cleavage furrow at the onset of anaphase. 
We tentatively termed it CF kinase (Cleavage Furrow ki- 
nase) and attempted to identify its activity directly, using 
GFAP as a substrate. As a first step, we monitored KT13- 
positive U251  cells after release from mitotic arrest with 
nocodazole to obtain the cell population expected to con- 
tain CF kinase activity. Fig. 4 a  shows that  >60%  of the 
cells  were  arrested  at  early  stages  during  mitosis  when 
treated with nocodazole. KT13-positive cells were first ob- 
served at 15 min after release from mitotic arrest (Fig. 4 b). 
The population of KT13-positive cells reached a peak (35- 
40%)  between  30  and 45  min  (Fig.  4, c  and  d)  and  de- 
creased gradually thereafter (Fig. 4, e and f). We then ana- 
lyzed  the  phosphorylation  of endogenous  GFAP  in  the 
U251  cells  at  30  min  after release,  by Western  blotting 
(Fig. 5). As shown in lane b of Fig. 5 C, KT13-immunore- 
active  band  at  50  kD  corresponding  to  the  position  of 
GFAP (Fig. 5 B) was detected only in this cell lysates. No 
KT13-immunoreactive band was detected in this lysate of 
The Journal of Cell Biology,  Volume 132, 1996  638 Figure  4.  Fluorescence  photomicro- 
graphs  showing  KT13-immunoreac- 
tive U251  cells after release from mi- 
totic arrest. U251  cells were arrested in 
metaphase with 50  ng/ml nocodazole. 
At 0 (a), 15 (b), 30 (c), 45  (d), 60  (e), 
and 240  (f) min  after removal of no- 
codazole. Cells were fixed and stained 
with KT13  (green)  and  PI  (red).  Bar 
represents 50/~m. 
metaphase  or interphase  cells  (Fig.  5  C,  lanes  a  and  c). 
Similar observations were  obtained with KT34  (data not 
shown). Therefore, we used the U251  cells at 30 min after 
release from mitotic arrest to search for CF kinase activity. 
Soluble fractions prepared from late mitotic cells were 
incubated in the presence or absence of purified GFAP as 
an exogenous substrate. As shown  in Fig. 6, this fraction 
specifically contained the kinase activity phosphorylating 
Serl3 and Ser34 of GFAP. In contrast, no or only a  very 
faint signal was detected in soluble fractions of metaphase 
or interphase cells (Fig. 6,  C  and D,  lanes b  and f). The 
possibility  that  the  KT13-  and  KT34-immunoreactive 
bands (Fig. 6, C  and D, lanes d) are derived from endoge- 
nous  phosphorylated  GFAP  was  ruled  out  because  no 
MO389-immunoreactive  band  was  detected  in  soluble 
fractions without  exogenous  GFAP  (Fig. 6  B,  lanes a,  c, 
and e). Thus, we detected CF kinase activity which is spe- 
cifically activated during late mitotic phase. 
Discussion 
Using phosphorylation state-specific monoclonal antibod- 
ies, we identified the phosphorylation of GFAP  at Serl3 
and  Ser34  during  late  mitotic phase  in  various  types  of 
cells,  regardless  of  species.  Furthermore,  we  detected  a 
protein  kinase  activity which  phosphorylates  Ser13  and 
Ser34 of GFAP specifically in soluble fractions of late mi- 
totic  U251  cells  but  not  in  those  of  interphase  or 
Figure  5.  Western  blot  analysis of  GFAP phosphorylation at 
Ser13 in U251  cell lysates. Lysates of 5 x  104 ceils were loaded on 
lanes,  resolved  by  SDS-PAGE,  and  transferred  onto  PVDF 
membrane. The blots were then stained with Coomassie Brilliant 
Blue (CBB)  (A), MO389 (B), or KT13 (C). Lane a, metaphase 
cells; lane b, late mitotic phase cells at 30 min after release from 
mitotic arrest; lane c, interphase cells. The position of GFAP is 
indicated by an arrowhead. 
Figure 6.  Detection of CF kinase activity in a soluble fraction of 
U251  cell lysates. Soluble fractions of U251  cell lysate (0.6  mg 
protein/ml) were incubated for 1 h in the absence (a, c, and e) or 
presence (b, d, and f) of purified GFAP (0.15 mg/ml) as an exoge- 
nous substrate. Each sample was resolved by SDS-PAGE, and 
transferred onto PVDF membrane. The blots were then stained 
with CBB (A), MO389 (B), KT13 (C), or KT34 (D). Lanes a and 
b, soluble fractions of metaphase cells; lanes c and d, soluble frac- 
tions of late mitotic phase cells at 30 min after release from mi- 
totic arrest; lanes e and f, soluble fractions of interphase cells. 
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tein kinase is activated at the onset of anaphase. 
In contrast to the mechanisms that execute and control 
cell  cycle events  at  G2-M  and  G1-S  transitions  (Hunt, 
1989,  1991;  Reed,  1992;  Pines,  1993;  Sherr,  1993;  Nigg, 
1993), much less is known of mechanisms at metaphase- 
anaphase  transition and during late mitotic phase of eu- 
karyotic cells. This is partly due to difficulties in arresting 
the cell cycle at metaphase-anaphase transition and in ob- 
taining cells highly enriched in late mitotic cells, for stan- 
dard biochemical analysis of cell cycle-dependent protein 
phosphorylation requires synchronized cells. The mono- 
clonal antibodies we developed in the present study over- 
came  these  difficulties  in  two  ways.  First,  immunocy- 
tochemical  analysis  with  the  antibodies  enabled  us  to 
detect cell cycle-dependent phosphorylation of GFAP in 
single cells in nonsynchronized cell preparations. In addi- 
tion,  KT13  and  KT34  recognize  the  site-specific  phos- 
phorylation of GFAP. Therefore, the data we obtained are 
far more specific compared to data obtained by the stan- 
dard assay using radiolabeled phosphate. 
The detection of CF kinase activity in late mitotic cells 
raises the question of the identity of the kinase.  Amino 
acid  sequences  flanking  Serl3  and  Ser34  provide some 
hints:  they do not contain consensus sequence preferen- 
tially phosphorylated by the family of proline-directed ki- 
nases such as cdc2 kinase, MAP kinase, and other mem- 
bers of the cyclin-dependent protein kinase  (cdk) family 
(Pearson and Kemp, 1991; Ando et al.,  1993).  Therefore, 
CF kinase may not belong to these kinases. We reported 
that both Serl3 and Ser34 on GFAP are phosphorylated 
by PKA and protein kinase C  (PKC) in vitro (Inagaki et 
al., 1990). However, these kinases also phosphorylate Ser8 
on GFAP in vitro (Inagaki et al., 1990) which is not phos- 
phorylated  during  late  mitotic  phase  (Matsuoka  et  al., 
1992).  Therefore, CF kinase appears to be neither PKA 
nor PKC.  Golsteyn et al.  (1994) reported cloning of the 
human Plkl  gene which is closely related to Drosophila 
polo and Saccharomyces cerevisiae CDC5. Both polo and 
CDC5  are  activated  during  late  mitotic  phase  and  are 
thought to be required for cell cycle progression (Fenton 
and Glover, 1993; Kitada et al., 1993). Human Plkl kinase 
activity was low during interphase and high during mitosis 
(Golsteyn et al., 1995). The kinase was already activated at 
the G2-M transition, and the kinetics of the activation of 
Plkl  were  indistinguishable  from  those  of cdc2  kinase 
(Golsteyn et al.,  1995).  This differs from our results that 
CF kinase is  activated at the onset of anaphase  (Fig. 6), 
and suggests that CF kinase and Plkl kinase are probably 
not identical. Interestingly, the intracellular localization of 
Plkl  was  shown  to  be  concentrated  within  postmitotic 
bridges of dividing cells when cells go through anaphase. 
Golsteyn et al.  (1995) suggested that Plkl is required for 
the dynamic function of the mitotic spindle during chro- 
mosome segregation. 
KT13 and KT34 were also useful to reveal the intracel- 
lular distribution of CF kinase activities. The activity was 
specifically localized in the cleavage furrow and between 
the daughter nuclei (Figs. 2 and 3). Mechanisms governing 
the activation of CF kinase in these restricted areas remain 
to be elucidated. However, the specific localization of the 
CF kinase activity in the area where the cytosol is pinched 
suggests that it may play an important role in separation of 
the daughter cells. In this context, one possible function of 
CF kinase activity may be to reorganize intermediate fila- 
ments, including GFAP filament, in the cleavage furrow. 
There is evidence which strongly suggests that phosphory- 
lation of intermediate filament proteins, including GFAP, 
regulates their morphological organization. In vitro stud- 
ies revealed that site-specific phosphorylation of interme- 
diate  filament proteins induced  disassembly  of the  fila- 
ment  structure  (Inagaki  et al.,  1987,  1988,  1990;  Evans, 
1988; Peter et al., 1990). In vivo experiments demonstrated 
that increase in intermediate filament protein phosphory- 
lation by microinjection of the catalytic subunit of PKA 
(Lamb et al., 1989), expression of the constitutively active 
form  of  Ca2+/calmodulin-dependent  protein  kinase  II 
(CaM kinase II) or PKC (Ogawara et al., 1995), or mitotic 
arrest with colcemid treatment (Franke et al., 1982; Chou 
et al.,  1990; Tsujimura et al., 1994b) led to the collapse of 
filaments into bundles and granular dot structures. Such 
reorganization of intermediate filaments may be required 
for separation of the cytosol in the cleavage furrow. We 
are now analyzing the influence of the blockade of CF ki- 
nase-induced GFAP phosphorylation on the GFAP fila- 
ment structure and cellular behavior, by introducing a mu- 
tant GFAP in which Ser13, Ser34, and Thr7 are changed to 
alanine into intermediate filament-negative SW-13 cells. 
In conclusion, we detected a  CF kinase activity which 
phosphorylates GFAP at the cleavage furrow during late 
mitotic phase.  The phosphorylation state-specific mono- 
clonal antibodies KT13 and KT34 proved to be powerful 
tools for the detection of CF kinase activity. Probably, CF 
kinase is not a kinase identified previously. Purification of 
the kinase is ongoing in order to investigate physiological 
functions and the mechanism of activation at the onset of 
anaphase. 
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